Identification and optimal postsurgical follow-up of patients with very low-risk papillary thyroid microcarcinomas

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 11, 2010, Pages 4882-4888

  Durante, Cosimo ^a   Attard, Marco ^b   Torlontano, Massimo ^c   Ronga, Giuseppe ^a   Monzani, Fabio ^d   Costante, Giuseppe ^e   Ferdeghini, Marco ^f   Tumino, Salvatore ^g   Meringolo, Domenico ^h   Bruno, Rocco ⁱ   De Toma, Giorgio ^a   Crocetti, Umberto ^c   Montesano, Teresa ^a   Dardano, Angela ^d   Lamartina, Livia ^a   Maniglia, Adele ^b   Giacomelli, Laura ^a   Filetti, Sebastiano ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Ospedali Riuniti Villa Sofia Cervello   (Italy)

^c CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^d UNIVERSITY OF PISA   (Italy)

^e UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^f UNIVERSITY OF VERONA   (Italy)

^g UNIVERSITY OF CATANIA   (Italy)

^h Ospedale di Bentivoglio   (Italy)

ⁱ Tinchi Pisticci Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROTROPIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CERVICAL ULTRASONOGRAPHY; CLINICAL ASSESSMENT; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; PAPILLARY THYROID MICROCARCINOMA; PATIENT IDENTIFICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK ASSESSMENT; THYROGLOBULIN BLOOD LEVEL; THYROID CANCER; THYROIDECTOMY; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 78049502547     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0762     Document Type: Article

References (35)

1. Leenhardt L, Grosclaude P, Chérié-Challine L 2004 Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 14:1056-1060 (Pubitemid 40076130)
2. Davies L, Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164-2167
3. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214
4. Lin KD, Lin JD, Huang MJ, Huang HS, Jeng LB, Chao TC, Ho YS 1997 Clinical presentations and predictive variables of thyroid microcarcinoma with distant metastasis. Int Surg 82:378-381
5. Sugitani I, Fujimoto Y 1999 Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors. Endocr J 46:209-216
6. Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH 2003 Papillary microcarcinoma of the thyroid: prognostic significance of lymph node metastasis and multifocality. Cancer 98:31-40
7. Mazzaferri EL 2007 Management of low-risk differentiated thyroid cancer. Endocr Pract 13:498-512
8. Ito Y, Miyauchi A 2007 A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid. Nat Clin Pract Endocrinol Metab 3:240-248 (Pubitemid 46310536)
9. Hay ID, Hutchinson ME, Gonzalez-Losada T, McIver B, Reinalda ME, Grant CS, Thompson GB, Sebo TJ, Goellner JR 2008 Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery 144:980-987; discussion 987-988
10. Arora N, Turbendian HK, Kato MA, Moo TA, Zarnegar R, Fahey 3rd TJ 2009 Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two? Thyroid 19:473-447
11. Tzvetov G, Hirsch D, Shraga-Slutzky I, Weinstein R, Manistersky Y, Kalmanovich R, Lapidot M, Grozinsky-Glasberg S, Singer J, Sulkes J, Shimon I, Benbassat C 2009 Well-differentiated thyroid carcinoma: comparison of microscopic and macroscopic disease. Thyroid 19:487-494
12. Yamashita H, Noguchi S, Murakami N, Toda M, Uchino S, Watanabe S, Kawamoto H 1999 Extracapsular invasion of lymph node metastasis: a good indicator of disease recurrence and poor prognosis in patients with thyroid microcarcinoma. Cancer 86:842-849
13. Mazzaferri EL 2006 Managing small thyroid cancers. JAMA 295: 2179-2182
14. Roti E, degli Uberti EC, Bondanelli M, Braverman LE 2008 Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eur J Endocrinol 159:659-673
15. Lin JD, Chao TC, Hsueh C, Kuo SF 2009 High recurrent rate of multicentric papillary thyroid carcinoma. Ann Surg Oncol 16:2609-2616
16. Mercante G, Frasoldati A, Pedroni C, Formisano D, Renna L, Piana S, Gardini G, Valcavi R, Barbieri V 2009 Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid 19:707-716
17. Sippel RS, Caron NR, Clark OH 2007 An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up. World J Surg 31:924-933
18. Biondi B, Filetti S, Schlumberger M 2005 Thyroid-hormone therapy and thyroid cancer: a reassessment. Nat Clin Pract Endocrinol Metab 1:32-40
19. Mazzaferri EL, Robbins RJ, Spencer CA, Braverman LE, Pacini F, Wartofsky L, Haugen BR, Sherman SI, Cooper DS, Braunstein GD, Lee S, Davies TF, Arafah BM, Ladenson PW, Pinchera A 2003 A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 88:1433-1441 (Pubitemid 36623351)
20. Schlumberger M, Berg G, Cohen O, Duntas L, Jamar F, Jarzab B, Limbert E, Lind P, Pacini F, Reiners C, Sánchez Franco F, Toft A, Wiersinga WM 2004 Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective. Eur J Endocrinol 150:105-112 (Pubitemid 38312801)
21. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W; European Thyroid Cancer Taskforce 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787-803
22. Smallridge RC, Meek SE, Morgan MA, Gates GS, Fox TP, Grebe S, Fatourechi V 2007 Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human TSH-stimulated thyroglobulin in follow-up of thyroid cancer patients. J Clin Endocrinol Metab 92:82-87
23. Vasallo P, Wernecke K, Roos N, Peters PE 1992 Differentiation of benign from malignant superficial lymphadenopathy: the role of high-resolution US. Radiology 183:215-220
24. Torlontano M, Attard M, Crocetti U, Tumino S, Bruno R, Costante G, D'Azzò G, Meringolo D, Ferretti E, Sacco R, Arturi F, Filetti S 2004 Follow-up of low-risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. J Clin Endocrinol Metab 89:3402-3407
25. Leboulleux S, Girard E, Rose M, Travagli JP, Sabbah N, Caillou B, Hartl DM, Lassau N, Baudin E, Schlumberger M 2007 Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab 92: 3590-3594
26. Bruno R, Giannasio P, Chiarella R, Capula C, Russo D, Filetti S, Costante G 2009 Identification of a neck lump as a lymph node metastasis from an occult contralateral papillary microcarcinoma of the thyroid: key role of thyroglobulin assay in the fine-needle aspirate. Thyroid 19:531-533
27. Arturi F, Russo D, Giuffrida D, Ippolito A, Perrotti N, Vigneri R, Filetti S 1997 Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. J Clin Endocrinol Metab 82:1638-1641
28. Russo D, Arturi F, Pontecorvi A, Filetti S 1999 Genetic analysis in fine-needle aspiration of the thyroid: a new tool for the clinic. Trends Endocrinol Metab 10:280-285 (Pubitemid 29403734)
29. Cailleux AF, Baudin E, Travagli JP, Ricard M, Schlumberger M 2000 Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? J Clin Endocrinol Metab 85:175-178
30. Antonelli A, Miccoli P, Ferdeghini M, Di Coscio G, Alberti B, Iacconi P, Baldi V, Fallahi P, Baschieri L 1995 Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer. Thyroid 5:25-28
31. Torlontano M, Crocetti U, D'Aloiso L, Bonfitto N, Di Giorgio A, Modoni S, Valle G, Frusciante V, Bisceglia M, Filetti S, Schlumberger M, Trischitta V 2003 Serum thyroglobulin and 131I whole body scan after recombinant human TSH stimulation in the follow- up of low-risk patients with differentiated thyroid cancer. Eur J Endocrinol 148:19-24
32. Frasoldati A, Pesenti M, Gallo M, Caroggio A, Salvo D, Valcavi R 2003 Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer 97:90-96
33. Pacini F, Molinaro E, Castagna MG, Agate L, Elisei R, Ceccarelli C, Lippi F, Taddei D, Grasso L, Pinchera A 2003 Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab 88:3668-3673
34. Torlontano M, Crocetti U, Augello G, D'Aloiso L, Bonfitto N, Varraso A, Dicembrino F, Modoni S, Frusciante V, Di Giorgio A, Bruno R, Filetti S, Trischitta V 2006 Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131I whole-body scintigraphy, and neck ultrasonography in the follow- up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine therapy. J Clin Endocrinol Metab 91: 60-63
35. Baudin E, Do Cao C, Cailleux AF, Leboulleux S, Travagli JP, Schlumberger M 2003 Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients. J Clin Endocrinol Metab 88:1107-1111